Second autologous stem cell transplant: an effective therapy for relapsed multiple myeloma.

Abstract

Therapeutic options for patients with multiple myeloma (MM) whose disease has relapsed after a prior autologous stem cell transplant (ASCT) include an expanding armamentarium of novel agents, often combined with traditional chemotherapy, or a second ASCT, with no clear standard of care. We retrospectively analyzed the outcomes of 75 patients who underwent… (More)
DOI: 10.1016/j.bbmt.2014.11.677

Topics

Cite this paper

@article{Abbi2015SecondAS, title={Second autologous stem cell transplant: an effective therapy for relapsed multiple myeloma.}, author={Kamal Kant Singh Abbi and Junting Zheng and Sean Devlin and Sergio A. Giralt and Heather J. Landau}, journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation}, year={2015}, volume={21 3}, pages={468-72} }